Use of fibrinolytic agents to coat wire implants to decrease infection. An animal model.

Nakamoto, D A; Haaga, J R; Bove, P; Merritt, K; Rowland, D Y

Nakamoto, D A; Haaga, J R; Bove, P; Merritt, K; Rowland, D Y.

Affiliation

Nakamoto DA; Department of Radiology, University Hospitals of Cleveland, OH 44106, USA.

Invest Radiol ; 30(6): 341-4, 1995 Jun.

Article in En | MEDLINE | ID: mdl-7490185

Subject(s)

Fibrinolytic Agents/therapeutic use; Heparin/therapeutic use; Plasminogen Activators/therapeutic use; Prostheses and Implants; Prosthesis-Related Infections/prevention & control; Stainless Steel; Staphylococcal Infections/prevention & control; Staphylococcus epidermidis; Urokinase-Type Plasminogen Activator/therapeutic use; Abscess/microbiology; Abscess/prevention & control; Animals; Bacterial Adhesion/drug effects; Bone Wires; Colony Count, Microbial; Connective Tissue/surgery; Cricetinae; Dermatologic Surgical Procedures; Disease Models, Animal; Equipment Contamination; Fibrinolytic Agents/administration & dosage; Heparin/administration & dosage; Plasminogen Activators/administration & dosage; Staphylococcus epidermidis/isolation & purification; Surface Properties; Urokinase-Type Plasminogen Activator/administration & dosage

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostheses and Implants / Stainless Steel / Staphylococcal Infections / Staphylococcus epidermidis / Heparin / Plasminogen Activators / Urokinase-Type Plasminogen Activator / Prosthesis-Related Infections / Fibrinolytic Agents Limits: Animals Language: En Journal: Invest Radiol Year: 1995 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links